【Standard Chem. & Pharm. Co., Ltd.】Announcement of Important Resolutions from the 2026 Annual General Meeting of Shareholders
Standard Chem. & Pharm. Co., Ltd. announced the important resolutions from its 2026 Annual General M… · 2026-05-12
生達 News Releases
Sheng Da Corporation Announces Board of Directors Approved Q1 2026 Consolidated Financial Report
Sheng Da Corporation announced its Q1 2026 consolidated financial report. The report shows operating… · 2026-05-12
[Sheng Ta] Announcement of the Board of Directors' Resolution to Waive Non-Compete Restrictions for a Director
Sheng Ta announced that its shareholders' meeting on May 12, 2026, approved a resolution to waive no… · 2026-05-12
【Standard Chem. & Pharm. Co., Ltd.】Announcement of Important Resolutions from the 2026 Annual General Meeting of Shareholders
Standard Chem. & Pharm. Co., Ltd. announced the important resolutions from its 2026 Annual General M… · 2026-05-12
Standard Chem. & Pharm. Corp.: Announcement of Improvement Plan Execution for Subsidiary Jiangsu Standard Biotech & Pharma Co., Ltd. Exceeding Loan Limits
Standard Chem. & Pharm. Corp.'s subsidiary, Jiangsu Standard Biotech & Pharma Co., Ltd., announced a… · 2026-05-12
Sheng Da Corporation Announces Board of Directors Approved Q1 2026 Consolidated Financial Report
Sheng Da Corporation announced its Q1 2026 consolidated financial report. The report shows operating… · 2026-05-12
[Sheng Ta] Announcement of the Board of Directors' Resolution to Waive Non-Compete Restrictions for a Director
Sheng Ta announced that its shareholders' meeting on May 12, 2026, approved a resolution to waive no… · 2026-05-12
Standard Chem. & Pharm. Corp.: Announcement of Improvement Plan Execution for Subsidiary Jiangsu Standard Biotech & Pharma Co., Ltd. Exceeding Loan Limits
Standard Chem. & Pharm. Corp.'s subsidiary, Jiangsu Standard Biotech & Pharma Co., Ltd., announced a… · 2026-05-12
Sheng Ta: Announcement of the Board Meeting Date for Q1 2026 Financial Report
Sheng Ta announced that its Board of Directors meeting is scheduled for May 12, 2026, to review and … · 2026-05-04
Sheng Ta: Announcement of the Board Meeting Date for Q1 2026 Financial Report
Sheng Ta announced that its Board of Directors meeting is scheduled for May 12, 2026, to review and … · 2026-05-04
[Standard Chem] May 2026 Monthly Revenue Reaches NT$581 Million (YoY -5.0%)
Standard Chem. & Pharm. Co., Ltd. (TWSE: 1720, Biotechnology & Medical Care) reported its revenue fo… · 2026-05-01
Standard Chem. & Pharm. Co., Ltd.: April 2026 Monthly Revenue Reaches TWD 677 Million (YoY +3.8%)
Standard Chem. & Pharm. Co., Ltd. announced its April 2026 monthly revenue reached TWD 677 million, … · 2026-04-01
Standard Chem. & Pharm. Co., Ltd.: April 2026 Monthly Revenue Reaches TWD 677 Million (YoY +3.8%)
Standard Chem. & Pharm. Co., Ltd. announced its April 2026 monthly revenue reached TWD 677 million, … · 2026-04-01
Shengda Announces March 2026 Revenue of NT$570 Million, Up 2.8% Year-on-Year
Shengda (stock code: 1720) reported its March 2026 revenue at NT$570.224 million, marking a 2.8% inc… · 2026-03-01
Shengda Announces March 2026 Revenue of NT$570 Million, Up 2.8% Year-on-Year
Shengda (stock code: 1720) reported its March 2026 revenue at NT$570.224 million, marking a 2.8% inc… · 2026-03-01
[Sheng Ta] February 2026 Monthly Revenue NT$466 Million (YoY -16.4%)
Sheng Ta (1720) released its financial report, showing that its February 2026 monthly revenue was NT… · 2026-02-01
[Sheng Ta] February 2026 Monthly Revenue NT$466 Million (YoY -16.4%)
Sheng Ta (1720) released its financial report, showing that its February 2026 monthly revenue was NT… · 2026-02-01